Epicrispr Biotechnologies vs Transcripta Bio
Epicrispr Biotechnologies vs Transcripta Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Transcripta Bio on 54/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 54/100
- funding raised: $90.0M against $24.0M
Transcripta Bio
- agent readiness: 49/100 against 39/100
At a glance
| Measure | Epicrispr Biotechnologies | Transcripta Bio |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Artificial Intelligence, Drug Discovery, Neurology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2020 | 2023 |
| Headquarters | South San Francisco, United States | Palo Alto, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Transcripta Bio |
|---|---|---|
| Employees | 51 | Not published |
| Total funding | $90.0M | $24.0M |
| Latest round | Series C | Series A |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Transcripta Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 54/100 |
| Traction | 57/100 | 37/100 |
| Team | 40/100 | 50/100 |
| Search visibility | 20/100 | 17/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Transcripta Bio |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Next.js, Tailwind CSS |
| Analytics | Google Analytics 4 | Google Analytics 4 |
What users say
| Measure | Epicrispr Biotechnologies | Transcripta Bio |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“Transcripta Bio Wins the Genomics Category 🧬💻. Transcripta Bio took home the trophy for Genomics, and for good reason. They are bridging the gap between massive transcriptomic data and actual drug candidates.”r/AIDiscoveryAward
Epicrispr Biotechnologies vs Transcripta Bio: common questions
Which is better, Epicrispr Biotechnologies or Transcripta Bio?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Transcripta Bio compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 54/100), funding raised ($90.0M against $24.0M). Transcripta Bio leads on agent readiness (49/100 against 39/100).
What do real users say about Epicrispr Biotechnologies and Transcripta Bio?
Transcripta Bio: 1 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/AIDiscoveryAward.
Read the full Epicrispr Biotechnologies review and pricing or the Transcripta Bio review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.